LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
LeonaBio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$5.05−0.15 (-2.88%)
Close on Oct 19, 2026
- Market cap
- $119.82M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
LeonaBio has not reported a dividend
No dividend per share appears in LeonaBio's annual filings since fiscal 2018.